Pediatrics international : official journal of the Japan Pediatric Society
-
Case Reports
Successful treatment of relapsing autoimmune thrombotic thrombocytopenic purpura with rituximab.
Thrombotic thrombocytopenic purpura (TTP) is a rare but life-threatening condition characterized by thrombotic microangiopathy. The standard treatment for TTP is plasmapheresis. ⋯ TTP is rarer in the pediatric age group and the use of rituximab in children with TTP is limited. Reported herein is the successful treatment of relapsing autoimmune TTP with rituximab in a 12-year-old girl.